FBC Funded Research
Every year, donors of Fighting Blindness Canada (FBC) fund research taking place in hospitals and universities across Canada, and around the world. This research is the backbone of our community and our primary…
Age Related Macular Degeneration
Overview Age-related macular degeneration (AMD) is the leading cause of vision loss in people over the age of 50, affecting approximately 1.4 million Canadians. The disease is “macular” because it damages the macula,…
2018 Impact Report
Fighting Blindness Canada (FBC) reached new heights in 2018, and now, as a community, we are poised to bring incredible and life-changing treatments to the millions of Canadians affected by eye diseases….
Game-Changing Discovery will “Rapidly Accelerate” the Development of Cell-Based Therapies
Today, we are excited to announce a truly transformative discovery that will “rapidly accelerate” the development of cell-based therapies—not just for blinding eye diseases, but for all kinds of regenerative medicine! One…
World Sight Day Announcement: the FBC launches the Cedric Ritchie Fund to Cure Blindness
The Canadian scientist Dr. Andras Nagy, Senior Investigator at Mount Sinai’s Lunenfeld-Tanenbaum Research Institute, was announced as the inaugural recipient of the Cedric Ritchie Fund to Cure Blindness: a new $1.5 million initiative…
Experimental Stem Cell Treatment for Macular Degeneration Restores Vision
Stem cells are making headlines again! This is good news, especially for those living with age-related macular degeneration (AMD), the most common blinding eye disease in people over the age of 50….
Join the Fight!
Learn how your support is helping to bring a future without blindness into focus! Be the first to learn about the latest breakthroughs in vision research and events in your community by subscribing to our eNews.